MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    IMPACT OF DEEP BRAIN STIMULATION ELECTRODE POSITION ON GAIT IN PATIENTS WITH PARKINSON’S DISEASE

    J. Bardoň, D. Burďáková, J. Valošek, D. Krahulík, P. Otruba, P. Kaňovský, M. Nevrlý (Olomouc, Czech Republic)

    Objective: The aim of our study is to evaluate the impact of the deep brain stimulation (DBS) electrode position within the subthalamic nucleus on gait…
  • 2022 International Congress

    Effects of gait symmetry manipulation on cortico-subthalamic interhemispheric coupling in parkinsonian patients by use of virtual reality

    J. Reuss, A. Gulberti, M. Knorr, M. Sengelmann, T. Schneider, M. Schaper, W. Hamel, A. Engel, C. Gerloff, C. Moll, M. Pötter-Nerger (Hamburg, Germany)

    Objective: The aim of this study is 1) to characterize gait-related neuronal oscillations and functional connectivity changes between cortico-subthalamic network nodes in Parkinson´s disease (PD)…
  • 2022 International Congress

    Is Increased Mineralisation of Putamen Relevant for Pathophysiology of Cervical Dystonia?

    Z. Kosutzka, M. Jezberova, I. Straka, P. Valkovic (Bratislava, Slovakia)

    Objective: To assess the susceptibility-weighted imaging in patients with idiopathic cervical dystonia Background: Susceptibility-weighted imaging (SWI) is an advanced MR imaging sequence that can be…
  • 2022 International Congress

    Defining minimal clinically important differences in Huntington’s disease: An anchor-based approach

    J. Hamilton, J. Mills, G. Stebbins, J. Long, R. Fuller, S. Sathe, M. Roche, C. Sampaio (Princeton, USA)

    Objective: This study aims to estimate the longitudinal minimal clinically important difference (MCID) for HD-relevant, cognitive, motor, and functional outcome measures. We used the new…
  • 2022 International Congress

    WATCH-PD: Baseline Phenotype and Longitudinal Digital Assessments in Early PD

    T. Kangarloo, E. Dorsey, P. Auinger, D. Volfson, J. Padmanabhan, B. Tracey, RS. Latzman, P. Artoni, Y. Gong, A. Best, J. Severson, D. Anderson, M. Kostrzebski, A. Stevenson, P. Wilmot, Y. Pohlson, J. Cosman, K. Praneeth Kilambi, J. Edgerton, J. Adams (Cambridge, USA)

    Objective: To provide a longitudinal profile of early Parkinson’s (PD) disease progression using clinical and digital measures, and to evaluate the extent to which digital…
  • 2022 International Congress

    Chorea Severity Change Over Time in Huntington Disease and by Huntington Disease Stage

    E. Furr Stimming, V. Sung, S. Reshef, R. Willock, R. Ribalov, S. Brighton, S. Leo (Houston, USA)

    Objective: To describe the evolution of chorea severity over time in individuals with Huntington disease (HD) stratified by Total Functional Capacity (TFC). Background: Chorea is…
  • 2022 International Congress

    Non-motor symptom characteristics in patients with essential tremor

    E. Jaakkola, E. Mäkinen, J. Joutsa, M. Eklund, S. Nuuttila, E. Honkanen, K. Lindholm, T. Noponen, T. Ihalainen, K. Murtomäki, T. Nojonen, R. Levo, T. Mertsalmi, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: The objective of this study was to evaluate non-motor symptoms in essential tremor (ET) and compare those to healthy controls (HCs). Background: ET is…
  • 2022 International Congress

    Evaluation of the association between total electrical energy delivered (TEED) and cognitive function six months after DBS in patients with Parkinson’s disease

    F. Ruggiero, F. Mameli, M. Dini, S. Marceglia, M. Prenassi, L. Borellini, F. Cogiamanian, E. Pirola, E. Zirone, D. Mellace, B. Capetti, L. Remore, G. Fiore, MR. Reitano, N. Maiorana, M. Locatelli, S. Barbieri, A. Priori, R. Ferrucci (Milan, Italy)

    Objective: We aimed to investigate the neuropsychological outcome six months after bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkison's disease (PD) patients and…
  • 2022 International Congress

    Cannabinoids for painful dystonia in corticobasal syndrome: a report of three patients

    G. Rizzo, P. Avoni, V. Donadio, R. Liguori (Bologna, Italy)

    Objective: We aimed to assess the efficacy of cannabinoids in painful dystonia of corticobasal syndrome (CBS) patients Background: The clinical phenotype of CBS includes limb…
  • 2022 International Congress

    USE OF NIGHT TIME CONTINUOUS SUBCUTANEOUS INFUSION OF APOMORPHINE (NCSAI) IN ADVANCED PARKINSON’S DISEASE: A SERIES OF 37 CASES.

    AK. Vargas Mendoza, B. López López, M. Díaz Castela, J. Molina Gil, P. Zunzunegui Arroyo, A. Criado Antón, ME. Suárez Sanmartín, C. García Fernández (Oviedo, Spain)

    Objective: The aim of this study is to evaluate the feasibility, efficacy and safety of NCSAI administration in patients with Advanced Parkinson disease (APD). Background:…
  • « Previous Page
  • 1
  • …
  • 659
  • 660
  • 661
  • 662
  • 663
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley